Discover Ipsos' end-to-end innovation research services. Powered by the collective intelligence of Ipsos human and artificial intelligence experts and solutions.
In this webinar, Ipsos will frame the latest dealmaking trends using recent transactions and market data, followed by a moderated discussion with active investors on what is changing in valuation, deal structures, and decision criteria, and what this means for pharma acquirers and innovator biotechs preparing for partnering conversations.
![[WEBINAR] Dealmaking 2026: What’s Changing, What’s Not, and How to Position for the Next Wave](/sites/default/files/styles/list_item_image/public/ct/event/2026-03/deal.png?itok=NtU1lGCc)
